Clinical trial

Outcome Analysis of POEM and Endoluminal Therapies

Invitation only · Not applicable · 1 countries · Registry ID NCT03123835

Invitation onlyNot applicableInterventional

What this study is about

Evaluation of current and newly developed endoluminal therapies in the management of Upper and Lower GI conditions.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 80 Years

SexAll

Healthy volunteersAccepted

ConditionAchalasia, Gastric Fistula, Weight Gain After Primary Weight Loss Surgery, Marginal Ulcer, Stenoses, Gastric Nec

Full registry criteria

Inclusion Criteria: * Adult male and female patients 18-80 years of age * Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s) * Gastrointestinal Reflux Disease * Achalasia * Barrett's Esophagus * Post Bariatric Surgery conditions * Other gastrointestinal and postsurgical disorders. Exclusion Criteria: * Adults unable to consent * Individuals that do not meet inclusion criteria or qualify for endoluminal treatment paradigms and internees.

Treatments and study arms

Endoscopic Intervention

Procedure

After reviewing all therapeutic options the patient will be offered the best therapeutic option to treat their condition. Surgical interventions include open laparotomy, diagnostic/therapeutic laparoscopy or endoluminal therapies. After the patient is consented for the related surgical intervention the patient will be given the option to participate in the clinical study to measure outcomes after surgery.

Primary outcomes

Decrease in GERDDQ3-6 months

Assessment will be made via post surgery questionnaire (decreasing in scoring will be 0-5)

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Univesity of California Davis Health System🇺🇸 Sacramento, California, United States

Open map